Company: DHR
Filing Date: 2025-07-22
Form Type: 10-Q
Source: 0000313616-25-000153
Chunk: 9

Company: DANAHER CORP /DE/
Filing Date: 2025-07-22
Form: 10-Q
Item: Item 1
Chunk 9
---
.10 $2.68 

NOTE 4.  REVENUE

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and six-month periods ended June 27, 2025 and June 28, 2024 ($ in millions).  Sales taxes and other usage-based taxes collected from customers are excluded from revenue.BiotechnologyLife SciencesDiagnosticsTotalFor the Three-Month Period Ended June 27, 2025:Geographical region:North America(a)$612 $762 $1,064 $2,438 Western Europe708 394 405 1,507 Other developed markets(b)82 118 94 294 High-growth markets(c)448 503 746 1,697 Total$1,850 $1,777 $2,309 $5,936 Revenue type:Recurring$1,694 $1,214 $2,062 $4,970 Nonrecurring156 563 247 966 Total$1,850 $1,777 $2,309 $5,936 For the Three-Month Period Ended June 28, 2024:Geographical region:North America(a)$607 $785 $1,042 $2,434 Western Europe567 374 380 1,321 Other developed markets(b)81 116 95 292 High-growth markets(c)458 495 743 1,696 Total$1,713 $1,770 $2,260 $5,743 Revenue type:Recurring$1,478 $1,208 $2,003 $4,689 Nonrecurring235 562 257 1,054 Total$1,713 $1,770 $2,260 $5,743 

8

BiotechnologyLife SciencesDiagnosticsTotalFor the Six-Month Period Ended June 27, 2025:Geographical region:North America(a)$1,155 $1,483 $2,382 $5,020 Western Europe1,274 772 805 2,851 Other developed markets(b)146 241 185 572 High-growth markets(c)887 961 1,386 3,234 Total$3,462 $3,457 $4,758